Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Future acceptance of an artificial pancreas in adults with type 1 diabetes.

van Bon AC, Brouwer TB, von Basum G, Hoekstra JB, DeVries JH.

Diabetes Technol Ther. 2011 Jul;13(7):731-6. doi: 10.1089/dia.2011.0013. Epub 2011 Apr 19.

PMID:
21504332
2.

Patients' perception and future acceptance of an artificial pancreas.

van Bon AC, Kohinor MJ, Hoekstra JB, von Basum G, deVries JH.

J Diabetes Sci Technol. 2010 May 1;4(3):596-602.

3.

Artificial pancreas (AP) clinical trial participants' acceptance of future AP technology.

Bevier WC, Fuller SM, Fuller RP, Rubin RR, Dassau E, Doyle FJ 3rd, Jovanovič L, Zisser HC.

Diabetes Technol Ther. 2014 Sep;16(9):590-5. doi: 10.1089/dia.2013.0365. Epub 2014 May 8.

4.

Use of a real-time continuous glucose monitoring system in children and young adults on insulin pump therapy: patients' and caregivers' perception of benefit.

Cemeroglu AP, Stone R, Kleis L, Racine MS, Postellon DC, Wood MA.

Pediatr Diabetes. 2010 May;11(3):182-7. doi: 10.1111/j.1399-5448.2009.00549.x. Epub 2009 Dec 2.

PMID:
19958460
5.
6.

A remote monitoring system for artificial pancreas support is safe, reliable, and user friendly.

Oron T, Farfel A, Muller I, Miller S, Atlas E, Nimri R, Phillip M.

Diabetes Technol Ther. 2014 Nov;16(11):699-705. doi: 10.1089/dia.2014.0090. Epub 2014 Sep 11.

PMID:
25211216
8.

Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.

Reimer T, Hohberg C, Pfützner AH, Jørgensen C, Jensen KH, Pfützner A.

Clin Ther. 2008 Dec;30(12):2252-62. doi: 10.1016/j.clinthera.2008.12.004.

PMID:
19167585
9.

Quality of life and diabetes knowledge of young persons with type 1 diabetes: Influence of treatment modalities and demographics.

O'Neil KJ, Jonnalagadda SS, Hopkins BL, Kicklighter JR.

J Am Diet Assoc. 2005 Jan;105(1):85-91.

PMID:
15635351
10.
11.
13.

Reduced Worries of Hypoglycaemia, High Satisfaction, and Increased Perceived Ease of Use after Experiencing Four Nights of MD-Logic Artificial Pancreas at Home (DREAM4).

Ziegler C, Liberman A, Nimri R, Muller I, Klemenčič S, Bratina N, Bläsig S, Remus K, Phillip M, Battelino T, Kordonouri O, Danne T, Lange K.

J Diabetes Res. 2015;2015:590308. doi: 10.1155/2015/590308. Epub 2015 Oct 25.

14.

Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire.

Martinez L, Consoli SM, Monnier L, Simon D, Wong O, Yomtov B, Guéron B, Benmedjahed K, Guillemin I, Arnould B.

Health Qual Life Outcomes. 2007 Aug 29;5:53.

15.
16.
17.

A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.

DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ; Dutch Insulin Pump Study Group.

Diabetes Care. 2002 Nov;25(11):2074-80.

PMID:
12401759
18.

A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes.

Fox LA, Buckloh LM, Smith SD, Wysocki T, Mauras N.

Diabetes Care. 2005 Jun;28(6):1277-81.

PMID:
15920039
19.

A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.

Herman WH, Ilag LL, Johnson SL, Martin CL, Sinding J, Al Harthi A, Plunkett CD, LaPorte FB, Burke R, Brown MB, Halter JB, Raskin P.

Diabetes Care. 2005 Jul;28(7):1568-73.

PMID:
15983302
20.

Preference for insulin delivery systems among current insulin users and nonusers.

Summers KH, Szeinbach SL, Lenox SM.

Clin Ther. 2004 Sep;26(9):1498-505.

PMID:
15531012

Supplemental Content

Support Center